Is Borosil Scientific a Good Buy After Its Q1 FY27 Results?
- September 9, 2026
- Posted by: Harsh Piplani
- Category: Market
Borosil Scientific share price around Rs 128. 29.5% below 52-week high of Rs 181. Q1 FY27 revenue Rs 109 crore, up 10.6% YoY. PAT Rs 4.36 crore, up 203.6%. PE 27x.
Quick Answer
Borosil Scientific’s Q1 FY27 results were strong, with revenue at Rs 109 crore and swinging from a loss of Rs 4.21 crore a year earlier to a profit of Rs 4.36 crore this quarter. The stock trades at a PE of 27x against an industry average near 38x, which leaves room for a re-rating if this growth continues. The Borosil Scientific share price near Rs 128 reflects that optimism, so investors weighing whether Borosil Scientific is a good buy today should focus on whether this pace of growth can be sustained rather than just this quarter’s print.
The Borosil Scientific share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Borosil Scientific is a laboratory and scientific glassware manufacturer, further demerged from Borosil Limited, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.
Revenue for the quarter came in at Rs 109 crore, up 10.6% year on year, while profit after tax came in at Rs 4.36 crore, up 203.6% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Borosil Scientific share price from here.
This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Borosil Scientific share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.
Click Here – Get Free Investment Predictions
Borosil Scientific Q1 FY27 Financial Highlights
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue | Rs 109 crore | Rs 99 crore | 10.6% |
| EBITDA | Rs 11 crore | Rs 7.79 crore | 42.9% |
| Operating Margin | 10.4% | 1.2% | NA |
| Profit Before Tax | Rs 5.99 crore | -Rs 4.08 crore | 246.8% |
| Net Profit / (Loss) | Rs 4.36 crore | -Rs 4.21 crore | 203.6% |
Borosil Scientific Q1 FY27 Performance Analysis
Check Borosil Scientific Fundamentals on Univest Screener
Revenue growth of 10.6% for the quarter came from steady demand across the company’s core business, keeping the topline trend intact for the laboratory and scientific glassware manufacturing sector.
The bigger story is the swing back to profit. Borosil Scientific posted a loss of Rs 4.21 crore in the year-ago quarter and turned that into a profit of Rs 4.36 crore this time, a genuine turnaround rather than just faster growth off an already-profitable base. This is the kind of quarter that supports the premium the Borosil Scientific share price already commands, though investors should check whether the turnaround is durable or helped by one-off factors.
On a sequential basis, revenue moved down 24.7% sequentially from Rs 145 crore in the March 2026 quarter and net profit moved down 84.0% sequentially from Rs 27 crore in the prior quarter, giving a fuller picture of the trend behind the Borosil Scientific share price than the year on year comparison alone.
Key Business Factors in Q1 FY27
Revenue Trend
Borosil Scientific’s revenue grew 10.6% year on year this quarter, taking the quarterly base to Rs 109 crore in a laboratory and scientific glassware manufacturing business that remains sensitive to demand and pricing cycles that ultimately feed through to the Borosil Scientific share price.
Margin Movement
EBITDA rose 42.9% to Rs 11 crore, and operating margin moved to 10.4% from 1.2% a year earlier, a sign that cost control or pricing held up during the quarter.
Balance Sheet Position
Borosil Scientific carries a low debt-to-equity ratio of 0.02, giving it a conservative balance sheet heading into the rest of FY27.
Valuation Context
The stock trades at a PE of 26.7x, below the industry average of 37.6x, which is worth factoring into any read of whether the Borosil Scientific share price is expensive or reasonably priced.
Dividend Details
No interim dividend was declared alongside Borosil Scientific’s Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Borosil Scientific share price for income should watch the company’s announcements around its next annual results for any dividend decision.
Borosil Scientific Share Price Outlook for FY27
The Q1 FY27 print sets a reasonably high bar for the rest of the year. If Borosil Scientific can sustain this pace of revenue and profit growth, the current valuation gets easier to justify. The main swing factor is whether this quarter’s momentum reflects a durable trend or a favourable one-off, something the next two quarters should clarify.
For the Borosil Scientific share price to hold its current premium through FY27, the company will likely need to keep posting growth at or near this quarter’s pace, since any slowdown would put pressure on a stock priced for continued strength.
Borosil Scientific Stock Performance
Download the Univest iOS App or Univest Android App to track Borosil Scientific’s live share price and get daily stock updates.
The Borosil Scientific share price was trading around Rs 128 as results season played out in late August 2026, roughly 29.5% below its 52-week high of Rs 181 and well above its 52-week low of Rs 97.
The Borosil Scientific share price has room to re-rate further if the growth shown this quarter continues, though much of the good news may already be reflected in the stock near current levels. On profitability ratios, the company reports a return on equity of 9.13% and a book value of around Rs 50 per share, both useful reference points when judging whether the current price is reasonable.
Key Risks
Sector and Demand Risk
As a laboratory and scientific glassware manufacturing business, Borosil Scientific’s results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Borosil Scientific share price well before the next result.
Execution Risk
Sustaining this quarter’s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.
Conclusion
Borosil Scientific’s Q1 FY27 results were genuinely strong, with revenue at Rs 109 crore and PAT up 204% to Rs 4.36 crore. That said, at a PE of 26.7x, the Borosil Scientific share price is not inexpensive, so this looks like a quality business trading at a full price rather than a bargain. Existing investors have little to worry about from this print, while new investors asking whether Borosil Scientific is a good buy should weigh the strong quarter against the valuation before adding at current levels.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Borosil Scientific Q1 FY27 Results
What were Borosil Scientific’s Q1 FY27 results?
Ans. Borosil Scientific reported Q1 FY27 revenue of Rs 109 crore, up 10.6% year on year, and PAT of Rs 4.36 crore, up 203.6% year on year.
Is Borosil Scientific a good buy after its Q1 FY27 results?
Ans. Borosil Scientific’s core numbers improved this quarter, though at a PE of 26.7x the stock is not inexpensive, so this suits investors comfortable paying up for quality. Investors should form their own view based on their own risk appetite and time horizon.
What is the Borosil Scientific share price today?
Ans. The Borosil Scientific share price was trading around Rs 128 in late August 2026, about 29.5% below its 52-week high of Rs 181 and well above its 52-week low of Rs 97.
What is Borosil Scientific’s revenue and profit for Q1 FY27?
Ans. Borosil Scientific reported revenue of Rs 109 crore and a net profit of Rs 4.36 crore for the quarter ended June 30, 2026.
Did Borosil Scientific declare a dividend with its Q1 FY27 results?
Ans. No interim dividend was declared alongside Borosil Scientific’s Q1 FY27 results. Investors should track the company’s next annual results for any dividend announcement.
What is Borosil Scientific’s PE ratio and is it expensive?
Ans. The Borosil Scientific share price trades at a trailing PE of 26.7x, against an industry average of 37.6x. Investors should compare this with the company’s growth rate before judging value.
What are the key risks for Borosil Scientific investors right now?
Ans. As a laboratory and scientific glassware manufacturing business, Borosil Scientific’s results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Borosil Scientific share price well before the next result. Sustaining this quarter’s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.
What is Borosil Scientific’s promoter shareholding?
Ans. Promoter shareholding data for Borosil Scientific was not fully available for this quarter and should be checked on the company’s official filings.
